Torrent Pharmaceuticals Ltd

Torrent Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Torrent Pharmaceuticals Ltd

₹ 2,791 0.71%
28 Jun - close price
torrentpharma.com BSE: 500420 NSE: TORNTPHARM
About

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]

It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

Key Points

Product Offerings
The company manufactures pharmaceutical products under various dosage forms such as oral solids, oral liquids, topicals, suppositories, Human insulin and synthetic APIs. API manufacturing is predominantly aimed at captive consumption.[1]

Website BSE NSE
  • Market Cap ₹ 94,466 Cr.
  • Current Price ₹ 2,791
  • High / Low ₹ 2,980 / 1,771
  • Stock P/E 69.6
  • Book Value ₹ 202
  • Dividend Yield 1.00 %
  • ROCE 20.9 %
  • ROE 20.4 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 74.2%

Cons

  • Stock is trading at 13.8 times its book value
  • The company has delivered a poor sales growth of 8.17% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
1,468 1,695 1,799 1,588 1,662 1,933 1,928 1,915 1,920 2,121 2,146 2,123 2,143
1,037 1,117 1,182 1,161 1,179 1,268 1,308 1,312 1,342 1,384 1,410 1,422 1,427
Operating Profit 431 578 617 427 483 665 620 603 578 737 736 701 716
OPM % 29% 34% 34% 27% 29% 34% 32% 31% 30% 35% 34% 33% 33%
91 50 54 37 61 29 11 15 26 11 15 -11 76
Interest 69 66 64 57 52 51 62 91 94 90 77 69 67
Depreciation 152 150 153 152 147 149 156 185 182 183 192 191 195
Profit before tax 301 412 454 255 345 494 413 342 328 475 482 430 530
Tax % 7% 34% 28% 33% 36% 34% 34% 32% 33% 32% 32% 31% 23%
279 274 326 170 221 327 272 234 219 323 327 297 410
EPS in Rs 8.24 8.10 9.63 5.02 6.53 9.66 8.04 6.91 6.47 9.54 9.66 8.78 12.11
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
2,760 3,358 3,468 5,439 4,551 4,244 5,762 6,168 6,451 6,742 7,695 8,533
2,076 2,294 2,624 2,990 3,424 3,337 4,149 4,251 4,259 4,642 5,230 5,643
Operating Profit 684 1,065 843 2,450 1,127 907 1,613 1,917 2,192 2,101 2,465 2,890
OPM % 25% 32% 24% 45% 25% 21% 28% 31% 34% 31% 32% 34%
89 32 306 292 300 332 382 237 118 204 82 91
Interest 37 58 173 180 202 294 481 430 334 236 298 303
Depreciation 72 79 180 213 269 384 579 607 610 602 672 761
Profit before tax 665 958 796 2,348 955 562 935 1,117 1,366 1,466 1,577 1,917
Tax % 18% 20% 22% 26% 11% 14% 20% 16% 17% 32% 33% 29%
546 762 623 1,743 854 482 745 939 1,138 991 1,051 1,357
EPS in Rs 16.15 22.53 18.42 51.51 25.24 14.24 22.03 27.73 33.62 29.30 31.07 40.10
Dividend Payout % 36% 22% 31% 34% 28% 49% 39% 58% 52% 82% 71% 70%
Compounded Sales Growth
10 Years: 10%
5 Years: 8%
3 Years: 10%
TTM: 11%
Compounded Profit Growth
10 Years: 6%
5 Years: 14%
3 Years: 6%
TTM: 33%
Stock Price CAGR
10 Years: 23%
5 Years: 29%
3 Years: 24%
1 Year: 47%
Return on Equity
10 Years: 20%
5 Years: 18%
3 Years: 18%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 42 85 85 85 85 85 85 85 85 85 169 169
Reserves 1,609 2,205 2,621 3,623 4,369 4,472 4,931 5,036 5,945 6,261 6,287 6,660
693 1,132 2,521 2,249 2,446 5,845 5,623 5,294 4,404 3,348 4,575 3,344
1,012 911 1,270 1,332 1,152 1,419 1,389 1,469 1,327 1,460 1,840 2,204
Total Liabilities 3,356 4,333 6,497 7,289 8,051 11,820 12,027 11,884 11,761 11,153 12,872 12,377
791 836 2,764 2,681 3,523 7,429 7,425 7,198 6,741 6,251 7,972 8,008
CWIP 276 508 628 984 473 447 498 536 588 568 698 204
Investments 190 322 434 918 936 625 486 135 314 368 361 463
2,098 2,667 2,672 2,705 3,119 3,319 3,618 4,016 4,118 3,966 3,841 3,702
Total Assets 3,356 4,333 6,497 7,289 8,051 11,820 12,027 11,884 11,761 11,153 12,872 12,377

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-69 310 1,065 2,403 676 929 1,232 1,580 1,573 2,140 2,265 2,893
-89 -326 -2,099 -584 -527 -4,207 -373 269 -316 -160 -2,326 -296
25 86 996 -1,326 -130 2,929 -928 -1,555 -1,581 -1,977 81 -2,577
Net Cash Flow -133 70 -38 493 19 -349 -69 294 -325 3 20 20

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 110 143 124 61 82 95 86 89 87 83 82 67
Inventory Days 260 253 263 299 272 425 321 336 418 344 273 268
Days Payable 168 175 212 205 144 254 138 152 142 119 104 130
Cash Conversion Cycle 202 222 175 155 209 267 269 273 364 308 251 205
Working Capital Days 100 144 120 53 120 100 51 49 159 149 116 102
ROCE % 35% 35% 22% 44% 17% 9% 13% 14% 16% 17% 18%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25% 71.25%
11.65% 11.53% 11.63% 10.88% 10.80% 11.37% 12.09% 12.04% 12.85% 13.15% 14.08% 14.14%
8.42% 8.72% 8.94% 9.74% 10.01% 9.40% 8.77% 8.89% 8.22% 7.91% 7.11% 7.15%
0.00% 0.00% 0.00% 0.00% 0.00% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10%
8.68% 8.50% 8.18% 8.14% 7.95% 7.87% 7.78% 7.71% 7.59% 7.59% 7.46% 7.34%
No. of Shareholders 64,52564,30967,20563,22962,93367,86665,23763,83161,57269,61269,11771,154

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls